This indicates that CX3CL1 (Fractalkine) expression is much higher in pro-inflammatory TME, suggesting the cancer-eradicating role of CX3CL1-CX3CR1 axis, possibly by inducing apoptosis in cancer or immune targeting of cancer cells leading to anti-cancer processes. This evidence concerns the gene CX3CL1 and cancer.